St. Jude takes No. 2 spot in ICD market

10/19/2006 | ·

Although its implantable cardioverter defibrillator sales declined by 2%, St. Jude Medical beat analysts' expectations when it posted $116 million in earnings. The company's CEO, Dan Starks, also announced that the company's third quarter was "the tipping point when St. Jude became the clear No. 2 in selling pacemakers and ICDs," overtaking Boston Scientific Corp.

View Full Article in: ·

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC